PO148 | ANALYTICAL DISCREPANCY IN PLATELET COUNTING REVEALING MYH9-RD: A CASE REPORT
Abstract
Background. MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by pathogenic variants in the MYH9 gene, encoding non-muscle myosin IIA. It is characterized by congenital macrothrombocytopenia, with giant platelets and a variable bleeding tendency, and may be associated with extra-hematological manifestations such as sensorineural hearing loss, nephropathy, cataracts, and liver enzyme abnormalities. Although thrombocytopenia is often stable over time, the condition is frequently underdiagnosed and may be misinterpreted as immune thrombocytopenia, leading to inappropriate management. Morphological hallmarks include giant platelets and Döhlelike inclusions in the neutrophil cytoplasm. Accurate diagnosis relies on integration of clinical, laboratory, and genetic findings, and is essential for appropriate patient management and follow-up. Case Report. A 31-year-old pregnant woman underwent routine first-trimester blood testing, revealing severe thrombocytopenia (5,000/μL) measured by impedance methodology, with otherwise normal hematological parameters. Platelet histogram and leukocyte scattergrams suggested the presence of giant platelets. Subsequent platelet counting using fluorescence methodology showed a higher value (19,000/μL), highlighting a significant discrepancy between the two methods. Peripheral blood smear examination confirmed true thrombocytopenia, excluded platelet clumping, and demonstrated numerous giant platelets, some comparable in size to erythrocytes. Additionally, basophilic cytoplasmic inclusions were observed in neutrophils. Further clinical history revealed a known diagnosis of MYH9-related disease, and the inclusions were interpreted as Döhle-like bodies, a pathognomonic feature of the condition. Longitudinal data showed persistently low but stable platelet counts (mean ~30,000/μL). No evidence of renal involvement was found, with no proteinuria or hematuria, while mild elevation of liver enzymes suggested possible hepatic involvement. The discrepancy between counting methods was attributed to the presence of macroplatelets, which may be misclassified as red blood cells inmpedance-based systems, whereas fluorescence methods provide more accurate platelet identification. Conclusions. This case highlights the importance of a comprehensive and integrated approach to thrombocytopenia, particularly during pregnancy, when common benign or gestational causes may obscure rare inherited conditions. Morphological evaluation of peripheral blood smear remains essential for identifying key diagnostic features such as giant platelets and neutrophil inclusions. The observed discrepancy between platelet counting methods underscores the limitations of impedance-based systems in the presence of macrothrombocytes and supports the use of fluorescence-based techniques for accurate quantification. Awareness of MYH9-related disease laboratory features is crucial to avoid misdiagnosis and inappropriate treatment, ensuring proper clinical management and follow-up.
Related
- Analytical discrepancy in platelet counting in MYH9–related disease: a case report
- PO073 | ANALYTICAL VARIABILITY IN FIBRINOGEN TESTING REVEALING FIBRINOGEN LONGMONT: A CASE REPORT
- Revealing the phytochemical diversity and bioactive potential of caterpillar mushroom (Cordyceps militaris L.) using analytical techniques
- Cervical Scrofula Revealing Miliary Tuberculosis and Previously Undiagnosed Advanced HIV: A Case Report
- Multiple Cold Abscesses Without Respiratory Symptoms Revealing Multifocal Tuberculosis: A Case Report
BibTeX
@article{girolamo2026po148,
title = {{PO148 | ANALYTICAL DISCREPANCY IN PLATELET COUNTING REVEALING MYH9-RD: A CASE REPORT}},
author = {Marco De Girolamo},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
month = oct,
url = {https://www.btvb.org/btvb/article/view/964},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - PO148 | ANALYTICAL DISCREPANCY IN PLATELET COUNTING REVEALING MYH9-RD: A CASE REPORT
AU - Marco De Girolamo
PY - 2026
DA - 2026/10/26
JO - Bleeding, Thrombosis and Vascular Biology
UR - https://www.btvb.org/btvb/article/view/964
AB - Background. MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by pathogenic variants in the MYH9 gene, encoding non-muscle myosin IIA. It is characterized by congenital macrothrombocytopenia, with giant platelets and a variable bleeding tendency, and may be associated with extra-hematological manifestations such as sensorineural hearing loss, nephropathy, cataracts, and liver enzyme abnormalities. Although thrombocytopenia is often stable over time, the condition is frequently underdiagnosed and may be misinterpreted as immune thrombocytopenia, leading to inappropriate management. Morphological hallmarks include giant platelets and Döhlelike inclusions in the neutrophil cytoplasm. Accurate diagnosis relies on integration of clinical, laboratory, and genetic findings, and is essential for appropriate patient management and follow-up. Case Report. A 31-year-old pregnant woman underwent routine first-trimester blood testing, revealing severe thrombocytopenia (5,000/μL) measured by impedance methodology, with otherwise normal hematological parameters. Platelet histogram and leukocyte scattergrams suggested the presence of giant platelets. Subsequent platelet counting using fluorescence methodology showed a higher value (19,000/μL), highlighting a significant discrepancy between the two methods. Peripheral blood smear examination confirmed true thrombocytopenia, excluded platelet clumping, and demonstrated numerous giant platelets, some comparable in size to erythrocytes. Additionally, basophilic cytoplasmic inclusions were observed in neutrophils. Further clinical history revealed a known diagnosis of MYH9-related disease, and the inclusions were interpreted as Döhle-like bodies, a pathognomonic feature of the condition. Longitudinal data showed persistently low but stable platelet counts (mean ~30,000/μL). No evidence of renal involvement was found, with no proteinuria or hematuria, while mild elevation of liver enzymes suggested possible hepatic involvement. The discrepancy between counting methods was attributed to the presence of macroplatelets, which may be misclassified as red blood cells inmpedance-based systems, whereas fluorescence methods provide more accurate platelet identification. Conclusions. This case highlights the importance of a comprehensive and integrated approach to thrombocytopenia, particularly during pregnancy, when common benign or gestational causes may obscure rare inherited conditions. Morphological evaluation of peripheral blood smear remains essential for identifying key diagnostic features such as giant platelets and neutrophil inclusions. The observed discrepancy between platelet counting methods underscores the limitations of impedance-based systems in the presence of macrothrombocytes and supports the use of fluorescence-based techniques for accurate quantification. Awareness of MYH9-related disease laboratory features is crucial to avoid misdiagnosis and inappropriate treatment, ensuring proper clinical management and follow-up.
SN - 2785-5309
ER -